Socorro Asset Management’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-144,519
Closed -$8.39M 30
2023
Q3
$8.39M Buy
144,519
+12,291
+9% +$753K 3.92% 4
2023
Q2
$8.46M Buy
132,228
+30,000
+29% +$2.01M 3.57% 10
2023
Q1
$7.09M Buy
102,228
+6,337
+7% +$447K 3.13% 17
2022
Q4
$6.9M Sell
95,891
-6,260
-6% -$472K 2.99% 19
2022
Q3
$7.26M Sell
102,151
-20,245
-17% -$1.47M 3.38% 11
2022
Q2
$9.42M Sell
122,396
-33,806
-22% -$2.57M 3.35% 11
2022
Q1
$11.4M Buy
156,202
+1,002
+0.6% +$67.3K 3.17% 12
2021
Q4
$9.68M Buy
+155,200
New +$9.1M 2.76% 21

Other funds holding BMY

Socorro Asset Management's BMY Position: Q4 2023 in Review

Socorro Asset Management sold out of Bristol-Myers Squibb (BMY) in Q4 2023, closing a stake of 144,519 shares — an estimated $8.39M sold.

Socorro Asset Management first reported a position in BMY in Q4 2021 and held it in 8 quarters. The position peaked at $11.4M in Q1 2022. 2,364 funds tracked by Wall St. Rank hold BMY as of Q4 2023.

  • Socorro Asset Management reported no remaining Bristol-Myers Squibb position as of Q4 2023 after selling out during the quarter.
  • Socorro Asset Management sold 144,519 Bristol-Myers Squibb shares in Q4 2023, an estimated $8.39M.
  • Socorro Asset Management first reported a position in Bristol-Myers Squibb in Q4 2021 and held it in 8 quarters.
  • Socorro Asset Management's Bristol-Myers Squibb position peaked at $11.4M in Q1 2022.
  • 2,364 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2023.

Based on Socorro Asset Management's 13F filing for Q4 2023, filed 13 Feb 2024.